Cost-benefit analysis of the Polish hepatitis B prevention programme

Vaccine

Volumn 18, Issue SUPPL. 1, 2000, Pages

  Wiewióra Pilecka, Danuta ^a  

^a SmithKline Beecham Pharmaceuticals   (Poland)

Author keywords

Cost benefit; Hepatitis B; Vaccination

Indexed keywords

HEPATITIS B VACCINE;

COST BENEFIT ANALYSIS; HEPATITIS B; HIGH RISK POPULATION; HUMAN; LIVER CANCER; LIVER CIRRHOSIS; POLAND; PREVALENCE; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; VACCINATION;

EID: 0343750677     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00465-X     Document Type: Article

References (1)

1. Demicheli V., Jefferson T.O. Cost-benefit analysis of the introduction of mass vaccination against hepatitis B in Italy. J. Public Health Med. 4:1992;367-375.